InflaRx share price logo

InflaRx

NASDAQ: IFRX

Small Cap

$2.10

+0.08

(+3.96%)

as on

InflaRx Stock Performance

as on August 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.03
    $2.12
    downward going graph

    3.33%

    Downside

    0.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.80
    $2.95
    downward going graph

    61.98%

    Downside

    40.42%

    Upside

    downward going graph

InflaRx share price movements today

Previous Close
$2.02
Open
$2.05
Volume
501.3K
Market Cap
$300.6M
Day's Low - High
$2.03 - $2.12
52 Week Low - High
$0.80 - $2.95

InflaRx Historical Returns

1 Month Return
+ 9.97 %
3 Month Return
-17.41 %
1 Year Return
+ 136.41 %
3 Year Return
-46.17 %
5 Year Return
-13.19 %

InflaRx Stock Fundamentals & Key Indicators

Check InflaRx market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$300.6M

EPS (TTM)

-0.4886

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.57

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.09836674754998283

EBITDA

-38.8M

Revenue (TTM)

-10.1K

Profit Margin

48201.61%

Return On Equity TTM

-58.00%

InflaRx Stock Valuation

Track how InflaRx P/E has moved over time to understand its valuation trends.

InflaRx in the last 5 years

  • Overview

  • Trends

Lowest (-4.13x)

December 31, 2022

Industry (-7.28x)

December 31, 2025

Today (-1.30x)

December 31, 2025

Highest (-1.30x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.30x

InflaRx vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of InflaRx with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
InflaRx image
InflaRx
BUY$300.6M-13.19%-3.5748201.61%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Moderna image
Moderna
BUY$25.3B-84.24%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for InflaRx Stock including INR - Dollar returns

The InflaRx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

InflaRx investment value today

Current value as on today

₹2,66,760

Returns

₹1,66,760

(+166.76%)

Returns from InflaRx Stock

₹1,43,365 (+143.37%)

Dollar Impact

₹23,395 (+23.39%)

Analyst Recommendation on InflaRx Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for InflaRx. Average target price of $7.91

InflaRx Share Price Target

Get share price movements and forecasts by analysts on InflaRx.

What analysts predicted

73.45%UPSIDE

Target Price

$7.91

Current Price

$2.1

Analyzed by

4 Analysts

Target

$7.91

InflaRx target price $7.91, a slight upside of 73.45% compared to current price of $2.1. According to 4 analysts rating.

Indian Investors' Interest in InflaRx Stock

Search interest for InflaRx Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

InflaRx Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
-
0
0
0
-
-
Gross Profit
0
0
0
-2
0
-2
0
-4
-
-
Operating Income
-12
-15
-15
-9
-13
-12
-9
-12
-7
-7
EBITDA
-9
-12
-17
-4
-8
-14
-12
-10
-5
-10
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-9
-12
-17
-5
-8
-14
-12
-10
-5
-10
Income Tax Expense
-
-
0
-
-
-
0
-
-
-
Net Income
-9
-13
-17
-5
-8
-14
-12
-10
-5
-10
Net Profit Margin
-511.93%
-5376.69%
158.60%
666984.16%
0.00%
-5985.37%
98.60%
14418.50%
0.00%
0.00%

InflaRx Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
0
0
0
Gross Profit
0
0
-
-
-
-
0
-3
-7
Operating Income
-19
-37
-56
-33
-47
-32
-44
-52
-48
EBITDA
-19
-37
-56
-33
-44
-28
-42
-45
-45
Interest Expense
2
-
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-29
-53
-33
-45
-29
-42
-46
-45
Income Tax Expense
-
-
-
-
-
-
-
0
0
Net Income
-24
-29
-53
-33
-45
-29
-42
-46
-45
Net Profit Margin
71.13%
0.00%
0.00%
0.00%
0.00%
0.00%
-743.67%
-1900.76%
-24677.94%

InflaRx Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-13
-17
-5
-8
-14
-12
-8
-5
-10
Operating Cash Flow
-14
-12
-9
-11
-14
-7
-9
-4
-7
-2
Investing Cash Flow
26
5
17
1
17
-24
2
7
6
13
Financing Cash Flow
0
0
0
0
27
0
0
6
0
121
Change in Cash
12
-5
7
-7
28
-34
-6
9
8
131

InflaRx Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-29
-53
-33
-45
-29
-42
-46
-43
Operating Cash Flow
-12
-23
-43
-36
-39
-33
-37
-48
-33
Investing Cash Flow
0
-99
20
21
-25
19
-17
52
3
Financing Cash Flow
108
49
0
9
61
1
52
0
32
Change in Cash
94
-67
-22
-7
0
-9
-3
5
0

Mutual Funds that own InflaRx Stock

Check out the Mutual Funds with significant holdings in InflaRx.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.029649%
43672

Global Institutional Holdings in InflaRx

Funds
Holdings
Peter Kolchinsky
1.34%
Luis Stuhlberger
0.17%
Invesco
0.03%

Insights on InflaRx

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, IFRX stock has moved up by 134.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 629.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 336.1%

About InflaRx

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction, biological proof of concept was established, demonstrating its unique C5a blocking ability and selectivity; Izicopan, an oral, low molecular weight drug to target C5aR with high affinity and selectivity has completed completing Phase 2a trials; and IFX002, an advancement of vilobelimab technology, which is in preclinical development for the treatment of chronic inflammatory indications. It has co-development agreement with Staidson (Beijing) BioPharmaceuticals Co., Ltd.; Cell line sales agreement with Catalent Pharma Solutions LLC; Clinical Trial Collaboration Agreement with the U.S. DHHSs, Administration for Strategic Preparedness and Response (ASPR), BARDA and PPD Development, L.P., or PPD. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
OrganisationInflaRx
HeadquartersWinzerlaer Str. 2, Jena, Germany, 07745
IndustryBiotechnology
CEOProf. Niels C. Riedemann M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of InflaRx

Name

Title

Prof. Renfeng Guo M.D.

Co-Founder, Chief Scientific Officer & Executive Director

Ms. Derval O'Carroll

Senior VP and Global Head of Regulatory Affairs & Compliance

Mr. Peter Hurt Ph.D.

Senior Director and Head of Drug Safety & Pharmacovigiliance

Mr. Daniel Vetter

Senior Director & Head of IT

Prof. Niels C. Riedemann M.D., Ph.D.

Co-Founder, CEO & Executive Director

Dr. Thomas Taapken Ph.D.

Chief Financial Officer

Mr. Jan Medina CFA

Head of Investor Relations & VP

Mr. Christian Schmid

VP and Head of Legal Affairs & General Counsel

Dr. Maria Habel PH.D.

VP, Head of Preclinical R&D and QC

Mr. Kofi Boaten

VP and Head of Supply Quality & Clinical Trial Supplies

FAQs

What is InflaRx share price today?

InflaRx share price today is $2.10 as on at the close of the market. InflaRx share today touched a day high of $2.12 and a low of $2.03.

What is the 52 week high and 52 week low for InflaRx share?

InflaRx share touched a 52 week high of $2.95 on and a 52 week low of $0.80 on . InflaRx stock price today i.e. is closed at $2.10,which is 28.79% down from its 52 week high and 163.03% up from its 52 week low.

What is InflaRx's market capitalisation today?

InflaRx market capitalisation is $0.00T as on .

How to invest in InflaRx Stock (IFRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for InflaRx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in InflaRx Shares that will get you 0.7143 shares as per InflaRx share price of $2.10 per share as on August 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy InflaRx Stock (IFRX) from India?

Indian investors can start investing in InflaRx (IFRX) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in InflaRx stock (as per the Rupee-Dollar exchange rate as on ). Based on InflaRx share’s latest price of $2.10 as on August 22, 2026 at 8:45 am IST, you will get 4.7619 shares of InflaRx. Learn more about fractional shares .

What are the returns that InflaRx has given to Indian investors in the last 5 years?

InflaRx stock has given -13.19% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?